Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Clobetasol nanocarriers can be effectively delivered to hair follicles, with uptake improved by massage and affected by particle type.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Benzalkonium chloride effectively treats skin fungus in guinea pigs.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

A new method accurately measures clobetasol propionate in hair and skin.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Demodicosis should be considered in cats with facial skin issues exposed to inhalant glucocorticoids.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Clofazimine may be effective for treating ashy dermatosis.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Hormonal therapies effectively treat acne and improve quality of life.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Combining probiotics, clotrimazole gel, and laser therapy improves treatment for recurrent yeast infections.